An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome
| Autor: | Begg, Malcolm, Amour, Augustin, Jarvis, Emily, Tang, Teresa, Franco, Sara Santos, Want, Andrew, Beerahee, Misba, Fernando, Disala, Karkera, Yakshitha, Sander, Clare, Southworth, Thomas, Singh, Dave, Clark, Jonathan, Nejentsev, Sergey, Okkenhaug, Klaus, Condliffe, Alison, Chandra, Anita, Cahn, Anthony, Hall, Edward Banham |
|---|---|
| Zdroj: | In Pulmonary Pharmacology & Therapeutics April 2023 79 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect